Soft Tissue Market worth $ 8.59 Billion by 2031 – Exclusive Report by Transparency Market Research

October 18 21:02 2021
Soft Tissue Market worth $ 8.59 Billion by 2031 - Exclusive Report by Transparency Market Research
Soft Tissue Market
Soft Tissue Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Soft Tissue Market: Introduction

According to the report, the global soft tissue market was valued at US$ 4.3 Mn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031. Soft tissue refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. Soft tissue allograft is used in ACL repair, joint reconstruction in the knee & ankle, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental procedures, shoulder repair, spinal fusion, and urological procedures. Different types of soft tissue allografts used for surgical procedure are cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The global soft tissue market is driven by better quality alternatives to autografts and technological advancements.

North America dominated the global soft tissue market in 2020 and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early adoption of new products, high prevalence rate of ACL surgeries, and presence of major players are expected to propel the soft tissue market in North America. Asia Pacific is likely to be a highly lucrative market for soft tissue during the forecast period. The market in the region is projected to expand at a high CAGR from 2021 to 2031.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82408

Better Quality Alternative to Autografts, Technological Advancements to Drive Global Market

Increase in usage of allograft and better alternative to autografts are anticipated to boost the growth of the global soft tissue market. Allograft efficacy in improving stability and function comparable to reconstruction with autologous tissue makes these better alternative to autografts. Soft tissue allografts are more biocompatible than synthetic products, reducing the rates of graft rejection. In an allograft procedure, donor site morbidity is avoided. Additionally, the procedure has benefits such as reduced hospital stay & cost and availability of a range of better quality alternatives to autografts with desired size and shape. Technological advancement is a major factor driving the demand for soft tissue products. Grafts made using dCELL technology give a patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength. PASCO2 technology, developed by Alamo Tissue Service, uses supercritical carbon-dioxide to extract unwanted compounds from soft tissue allografts.

Collagen Allografts to Dominate Soft Tissue Market

In terms of product type, the global soft tissue market has been classified into cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The tendon allografts segment has been split into Achilles tendon, patellar tendon, and others. The ligament allografts segment has been bifurcated into anterior cruciate ligament and medial collateral ligament. The collagen allografts segment dominated the global soft tissue market in 2020 and the trend is expected to continue during the forecast period.

The rise in the number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Moreover, usage of collagen allografts in maxillofacial surgery and wound care therapies is projected to drive the segment during the forecast period. Dental allografts was the second largest segment in terms of market share in 2020. Increase in regional import of surgical and dental allografts, allograft substitutes, and other acellular dermal matrix is likely to boost the segment.

Buy Soft Tissue Market Report at – https://www.transparencymarketresearch.com/checkout.php?rep_id=82408&ltype=S

Hospitals held Significant Market Share

In terms of end user, the global soft tissue market has been divided into hospitals, orthopedic clinics, and others. The hospitals segment led the global soft tissue market in terms of revenue in 2020 and the trend is projected to continue during the forecast period. Hospitalization for orthopedic surgeries and diabetic foot ulcers is anticipated to propel the hospitals segment. Moreover, increase in usage of soft tissue allografts for the treatment of burns and wound management contributes to the segment’s large market share. The segment is also driven by surge in number of surgeries and hospital facilities across the world.

North America to Dominate Soft Tissue Market

In terms of region, the global soft tissue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global soft tissue market in 2020, followed by Europe. North America’s large market share can be ascribed to technologically advanced research and treatment platforms, rise in anterior cruciate ligament injuries, new product launches, and presence of major players. The soft tissue market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2031. This can be ascribed to developing countries being commercial hubs, expanding business organizations, rising awareness about soft tissue allografts, improving healthcare infrastructure, and increasing investments by companies.

Competition Landscape of Soft Tissue Market

The global soft tissue market is fragmented due to the presence of a large number of players. Key players operating in the global market include Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc.

Trending Reports of Transparency Market Research –

Genome Engineering Market –

https://www.prnewswire.com/news-releases/efforts-of-pharmaceutical-companies-toward-development-of-new-treatment-solutions-create-lucrative-avenues-in-genome-engineering-market-notes-tmr-301364258.html

For more research insights on leading industries, visit our YouTube channel and hit subscribe for future update – 

https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ/videos

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact
Company Name: Transparency Market Research
Contact Person: Mr. Rohit Bhisey
Email: Send Email
Phone: 5186181030
Address:90 State Street, Suite 700
City: Albany
State: New York
Country: United States
Website: https://www.transparencymarketresearch.com/